Myriad Genetics (NASDAQ:MYGN) Cut to “Hold” at StockNews.com
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday. Several other equities research analysts also recently commented on the company. Stephens reissued an “equal weight” rating and issued a $20.00 price objective on shares of Myriad Genetics in […]
